186 related articles for article (PubMed ID: 34662196)
1. Analogs of Marinopyrrole A Show Enhancement to Observed
Martens MC; Liu Y; Sanford AG; Wallick AI; Warner RC; Li R; Davis PH
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0079421. PubMed ID: 34662196
[TBL] [Abstract][Full Text] [Related]
2. Two old drugs, NVP-AEW541 and GSK-J4, repurposed against the Toxoplasma gondii RH strain.
Liu S; Wu M; Hua Q; Lu D; Tian Y; Yu H; Cheng L; Chen Y; Cao J; Hu X; Tan F
Parasit Vectors; 2020 May; 13(1):242. PubMed ID: 32393321
[TBL] [Abstract][Full Text] [Related]
3. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
4. In vitro evaluation of new 4-thiazolidinones on invasion and growth of Toxoplasma gondii.
Molina DA; Ramos GA; Zamora-Vélez A; Gallego-López GM; Rocha-Roa C; Gómez-Marin JE; Cortes E
Int J Parasitol Drugs Drug Resist; 2021 Aug; 16():129-139. PubMed ID: 34102589
[TBL] [Abstract][Full Text] [Related]
5. Identification of fungal natural products with potent inhibition in
Jiang T; Godinez-Macias KP; Collins JE; Lee JW; Wendt KL; Carolino K; Chakrabarti D; Cichewicz RH; Winzeler EA
Microbiol Spectr; 2024 Apr; 12(4):e0414223. PubMed ID: 38421191
[TBL] [Abstract][Full Text] [Related]
6. Activity of (1-benzyl-4-triazolyl)-indole-2-carboxamides against Toxoplasma gondii and Cryptosporidium parvum.
Khan SM; Garcia Hernandez A; Allaie IM; Grooms GM; Li K; Witola WH; Stec J
Int J Parasitol Drugs Drug Resist; 2022 Aug; 19():6-20. PubMed ID: 35462232
[TBL] [Abstract][Full Text] [Related]
7. Two small-molecule inhibitors of
Hua QQ; Lin XJ; Xiang SP; Jiang LY; Cai JH; Sun JM; Tan F; Mou YN
Front Cell Infect Microbiol; 2023; 13():1145824. PubMed ID: 37077525
[TBL] [Abstract][Full Text] [Related]
8. Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites.
Portes JA; De Souza W
Parasitol Res; 2019 Dec; 118(12):3479-3489. PubMed ID: 31728720
[TBL] [Abstract][Full Text] [Related]
9. Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis.
Andrade RM; Chaparro JD; Capparelli E; Reed SL
PLoS Negl Trop Dis; 2014; 8(7):e2973. PubMed ID: 25079790
[TBL] [Abstract][Full Text] [Related]
10. Rapid discovery of inhibitors of Toxoplasma gondii using hybrid structure-based computational approach.
Kortagere S; Mui E; McLeod R; Welsh WJ
J Comput Aided Mol Des; 2011 May; 25(5):403-11. PubMed ID: 21359560
[TBL] [Abstract][Full Text] [Related]
11. Human toxoplasmosis-Searching for novel chemotherapeutics.
Antczak M; Dzitko K; Długońska H
Biomed Pharmacother; 2016 Aug; 82():677-84. PubMed ID: 27470411
[TBL] [Abstract][Full Text] [Related]
12. In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against
Ma Y; Cao X; Wang H; Song X; Hu D
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076987
[No Abstract] [Full Text] [Related]
13. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
[No Abstract] [Full Text] [Related]
14. Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.
Rosowsky A; Papoulis AT; Forsch RA; Queener SF
J Med Chem; 1999 Mar; 42(6):1007-17. PubMed ID: 10090784
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
16. In vitro antagonistic and indifferent activity of combination of 3-deoxyanthocyanidins against Toxoplasma gondii.
Abugri DA; Witola WH; Jaynes JM
Parasitol Res; 2017 Dec; 116(12):3387-3400. PubMed ID: 29086004
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro anti-Toxoplasma gondii activity of a new series of aryloxyacetophenone thiosemicarbazones.
Ansari M; Montazeri M; Daryani A; Farshadfar K; Emami S
Mol Divers; 2020 Nov; 24(4):1223-1234. PubMed ID: 31485890
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Activity between Statins and Bisphosphonates against Acute Experimental Toxoplasmosis.
Li ZH; Li C; Szajnman SH; Rodriguez JB; Moreno SNJ
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559264
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antiretroviral compounds against Toxoplasma gondii in vitro.
Wang JL; Elsheikha HM; Li TT; He JJ; Bai MJ; Liang QL; Zhu XQ; Cong W
Int J Antimicrob Agents; 2019 Dec; 54(6):814-819. PubMed ID: 31479744
[TBL] [Abstract][Full Text] [Related]
20. Anti-Toxoplasma activity of Sorghum bicolor-derived lipophilic fractions.
Abugri DA; Jaynes JM; Witola WH
BMC Res Notes; 2019 Oct; 12(1):688. PubMed ID: 31651353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
